Immudex's Grant

Immudex raised a round of funding on April 30, 2015. Investors include Markeds Modningsfonden.

Immudex provides a range of high quality products all based on the unique MHC Dextramer technology. MHC Dextramers are fluorescent MHC multimer reagents, developed for sensitive, specific and accurate…

Articles about Immudex's Grant: